National International Holding Company K.S.C.P. (KWSE:NIH)
Kuwait · Delayed Price · Currency is KWD · Price in KWF 0.1800
-0.0040 (-2.17%)
At close: Aug 6, 2026
KWSE:NIH Income Statement
Financials in millions KWD. Fiscal year is January - December.
Millions KWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 3.97 | 4.06 | 4.04 | 4.46 | 4.32 | 3.34 |
Other Revenue | 0.47 | 2.52 | 4.13 | 3.49 | 2.52 | 2.51 |
| 4.44 | 6.58 | 8.18 | 7.95 | 6.84 | 5.85 | |
Revenue Growth | -51.33% | -19.50% | 2.82% | 16.25% | 16.92% | 3620.84% |
Cost of Revenue | 2.79 | 2.93 | 2.94 | 3.39 | 3.39 | 2.39 |
Gross Profit | 1.65 | 3.65 | 5.23 | 4.56 | 3.45 | 3.46 |
Selling, General & Admin | 1.71 | 1.76 | 1.6 | 1.73 | 1.57 | 1.53 |
Other Operating Expenses | 0 | 0.03 | 0.03 | 0.03 | 0 | -0.07 |
Operating Expenses | 1.75 | 1.83 | 1.63 | 1.75 | 1.58 | 1.46 |
Operating Income | -0.1 | 1.82 | 3.61 | 2.8 | 1.87 | 1.99 |
Interest Expense | -0.16 | -0.22 | -0.22 | -0.24 | -0.16 | -0.14 |
Other Non Operating Income (Expenses) | 0 | -0.01 | -0 | -0 | - | -0 |
EBT Excluding Unusual Items | -0.26 | 1.59 | 3.38 | 2.56 | 1.71 | 1.85 |
Gain (Loss) on Sale of Investments | - | - | -1.52 | - | - | - |
Gain (Loss) on Sale of Assets | - | - | - | - | -0.01 | -0.05 |
Asset Writedown | 0.31 | 0.31 | - | - | - | -0 |
Pretax Income | 0.05 | 1.9 | 1.87 | 2.56 | 1.7 | 1.8 |
Income Tax Expense | -0.01 | 0.01 | 0.01 | 0.01 | 0 | 0 |
Earnings From Continuing Operations | 0.06 | 1.89 | 1.86 | 2.55 | 1.7 | 1.8 |
Minority Interest in Earnings | 0.04 | 0.02 | -0.22 | -0.28 | 0.03 | -0 |
Net Income | 0.1 | 1.91 | 1.64 | 2.28 | 1.72 | 1.79 |
Net Income to Common | 0.1 | 1.91 | 1.64 | 2.28 | 1.72 | 1.79 |
Net Income Growth | -96.04% | 16.21% | -28.04% | 32.36% | -4.03% | - |
Shares Outstanding (Basic) | 255 | 255 | 253 | 252 | 240 | 233 |
Shares Outstanding (Diluted) | 255 | 255 | 253 | 252 | 240 | 233 |
Shares Change | -0.60% | 1.03% | 0.29% | 5.02% | 2.86% | -2.25% |
EPS (Basic) | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
EPS (Diluted) | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
EPS Growth | -96.02% | 15.02% | -28.24% | 26.02% | -6.70% | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -0.1 | 1.86 | -1.19 | -0.4 | -0.85 | 0.91 |
Free Cash Flow Per Share | - | 0.01 | -0.01 | -0.00 | -0.00 | 0.00 |
Dividend Per Share | 0.002 | 0.002 | - | 0.005 | 0.004 | 0.004 |
Dividend Growth | - | - | - | 20.00% | 2.27% | - |
Gross Margin | 37.10% | 55.45% | 64.01% | 57.31% | 50.37% | 59.08% |
Operating Margin | -2.24% | 27.64% | 44.10% | 35.25% | 27.32% | 34.10% |
Profit Margin | 2.27% | 28.95% | 20.06% | 28.66% | 25.17% | 30.66% |
Free Cash Flow Margin | -2.16% | 28.28% | -14.50% | -5.06% | -12.47% | 15.49% |
EBITDA | 0.04 | 1.95 | 3.78 | 2.89 | 2.05 | 2.13 |
EBITDA Margin | 0.81% | 29.70% | 46.29% | 36.41% | 29.97% | 36.43% |
D&A For EBITDA | 0.14 | 0.14 | 0.18 | 0.09 | 0.18 | 0.14 |
EBIT | -0.1 | 1.82 | 3.61 | 2.8 | 1.87 | 1.99 |
EBIT Margin | -2.24% | 27.64% | 44.10% | 35.25% | 27.32% | 34.10% |
Effective Tax Rate | - | 0.34% | 0.30% | 0.24% | 0.00% | 0.15% |
Revenue as Reported | 4.75 | 6.89 | 8.18 | 7.95 | 6.83 | 5.88 |